• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素反应元件的全球鉴定

Global identification of androgen response elements.

作者信息

Massie Charles E, Mills Ian G

机构信息

Cancer Research UK, Cambridge Research Institute, Cambridge, UK.

出版信息

Methods Mol Biol. 2011;776:255-73. doi: 10.1007/978-1-61779-243-4_15.

DOI:10.1007/978-1-61779-243-4_15
PMID:21796531
Abstract

Chromatin immunoprecipitation (ChIP) is an invaluable tool in the study of transcriptional regulation. ChIP methods require both a priori knowledge of the transcriptional regulators which are important for a given biological system and high-quality specific antibodies for these targets. The androgen receptor (AR) is known to play essential roles in male sexual development, in prostate cancer and in the function of many other AR-expressing cell types (e.g. neurons and myocytes). As a ligand-activated transcription factor the AR also represents an endogenous, inducible system to study transcriptional biology. Therefore, ChIP studies of the AR can make use of treatment contrast experiments to define its transcriptional targets. To date several studies have mapped AR binding sites using ChIP in combination with genome tiling microarrays (ChIP-chip) or direct sequencing (ChIP-seq), mainly in prostate cancer cell lines and with varying degrees of genomic coverage. These studies have provided new insights into the DNA sequences to which the AR can bind, identified AR cooperating transcription factors, mapped thousands of potential AR regulated genes and provided insights into the biological processes regulated by the AR. However, further ChIP studies will be required to fully characterise the dynamics of the AR-regulated transcriptional programme, to map the occupancy of different AR transcriptional complexes which result in different transcriptional output and to delineate the transcriptional networks downstream of the AR.

摘要

染色质免疫沉淀(ChIP)是转录调控研究中一项非常重要的工具。ChIP方法既需要对特定生物系统中重要的转录调节因子有先验知识,也需要针对这些靶点的高质量特异性抗体。已知雄激素受体(AR)在男性性发育、前列腺癌以及许多其他表达AR的细胞类型(如神经元和心肌细胞)的功能中发挥着重要作用。作为一种配体激活的转录因子,AR也是研究转录生物学的内源性可诱导系统。因此,对AR的ChIP研究可以利用处理对照实验来确定其转录靶点。迄今为止,已有多项研究结合基因组平铺微阵列(ChIP-chip)或直接测序(ChIP-seq),主要在前列腺癌细胞系中使用ChIP来绘制AR结合位点,且基因组覆盖程度各不相同。这些研究为AR能够结合的DNA序列提供了新的见解,鉴定了与AR协同作用的转录因子,绘制了数千个潜在的AR调控基因,并为AR调控的生物学过程提供了见解。然而,还需要进一步的ChIP研究来全面表征AR调控的转录程序的动态变化,绘制导致不同转录输出的不同AR转录复合物的占据情况,并描绘AR下游的转录网络。

相似文献

1
Global identification of androgen response elements.雄激素反应元件的全球鉴定
Methods Mol Biol. 2011;776:255-73. doi: 10.1007/978-1-61779-243-4_15.
2
Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.整合基因表达的帽分析和染色质免疫沉淀分析阵列揭示了前列腺癌细胞中的全基因组雄激素受体信号。
Oncogene. 2011 Feb 3;30(5):619-30. doi: 10.1038/onc.2010.436. Epub 2010 Oct 4.
3
Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis.通过结合染色质免疫沉淀和基因组微阵列分析鉴定前列腺癌细胞中的新型雄激素反应基因。
Oncogene. 2007 Jun 28;26(30):4453-63. doi: 10.1038/sj.onc.1210229. Epub 2007 Feb 5.
4
FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells.FOXP1是一种雄激素反应性转录因子,它在前列腺癌细胞中负向调节雄激素受体信号传导。
Biochem Biophys Res Commun. 2008 Sep 19;374(2):388-93. doi: 10.1016/j.bbrc.2008.07.056. Epub 2008 Jul 18.
5
Amyloid precursor protein is a primary androgen target gene that promotes prostate cancer growth.淀粉样前体蛋白是一种促进前列腺癌生长的主要雄激素靶基因。
Cancer Res. 2009 Jan 1;69(1):137-42. doi: 10.1158/0008-5472.CAN-08-3633.
6
Identification and functional analysis of consensus androgen response elements in human prostate cancer cells.人前列腺癌细胞中共识雄激素反应元件的鉴定与功能分析。
Biochem Biophys Res Commun. 2004 Dec 24;325(4):1312-7. doi: 10.1016/j.bbrc.2004.10.174.
7
Regulation of FGF8 expression by the androgen receptor in human prostate cancer.雄激素受体对人前列腺癌中FGF8表达的调控
Oncogene. 2002 Aug 1;21(33):5069-80. doi: 10.1038/sj.onc.1205663.
8
Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region.雄激素通过其 3'非翻译区调节前列腺肿瘤抑制因子 NKX3.1。
Biochem J. 2010 Jan 15;425(3):575-83. doi: 10.1042/BJ20091109.
9
Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells.鉴定ETS样转录因子4为前列腺癌细胞中一种新的雄激素受体靶点。
Oncogene. 2008 Aug 21;27(36):4865-76. doi: 10.1038/onc.2008.125. Epub 2008 May 12.
10
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对雄激素信号通路的转录调控。
Anticancer Res. 2001 Jan-Feb;21(1A):1-10.

引用本文的文献

1
From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.从组学到多组学方法深入分析前列腺癌的分子机制。
Int J Mol Sci. 2022 Jun 3;23(11):6281. doi: 10.3390/ijms23116281.
2
Effect of aberrantly methylated androgen receptor target gene PCDH7 on the development of androgen-independent prostate cancer cells.雄激素受体靶基因 PCDH7 异常甲基化对雄激素非依赖性前列腺癌细胞发展的影响。
Genes Genomics. 2020 Mar;42(3):299-307. doi: 10.1007/s13258-019-00903-w. Epub 2019 Dec 23.
3
The importance of non-nuclear AR signaling in prostate cancer progression and therapeutic resistance.
非核雄激素受体信号传导在前列腺癌进展和治疗耐药性中的重要性。
Cell Signal. 2016 May;28(5):348-356. doi: 10.1016/j.cellsig.2016.01.013. Epub 2016 Jan 29.
4
Epigenetic and oncogenic regulation of SLC16A7 (MCT2) results in protein over-expression, impacting on signalling and cellular phenotypes in prostate cancer.SLC16A7(MCT2)的表观遗传和致癌调控导致蛋白质过度表达,影响前列腺癌中的信号传导和细胞表型。
Oncotarget. 2015 Aug 28;6(25):21675-84. doi: 10.18632/oncotarget.4328.
5
The co-chaperone p23 promotes prostate cancer motility and metastasis.共伴侣蛋白p23促进前列腺癌的运动性和转移。
Mol Oncol. 2015 Jan;9(1):295-308. doi: 10.1016/j.molonc.2014.08.014. Epub 2014 Sep 6.
6
Targeting androgen receptor action for prostate cancer treatment: does the post-receptor level provide novel opportunities?靶向雄激素受体作用用于前列腺癌治疗:受体后水平是否提供了新的机遇?
Int J Biol Sci. 2014 Jun 1;10(6):576-87. doi: 10.7150/ijbs.8479. eCollection 2014.
7
Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.异常 ETS 转录因子的潜在下游靶基因在尤文肉瘤和前列腺癌中受到不同的影响。
PLoS One. 2012;7(11):e49819. doi: 10.1371/journal.pone.0049819. Epub 2012 Nov 19.
8
Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements.原发性前列腺癌的分子亚型揭示了不同 ETS 重排的特定和共有靶基因。
Neoplasia. 2012 Jul;14(7):600-11. doi: 10.1593/neo.12600.
9
Direct cooperation between androgen receptor and E2F1 reveals a common regulation mechanism for androgen-responsive genes in prostate cells.雄激素受体与E2F1之间的直接合作揭示了前列腺细胞中雄激素反应基因的共同调控机制。
Mol Endocrinol. 2012 Sep;26(9):1531-41. doi: 10.1210/me.2012-1016. Epub 2012 Jul 6.